1st Circ. Won't Revive Spinal Therapy Co. Investor Suit
A spinal cord therapy company once again dodged a putative class action by investors alleging it lied in public statements about drug trial opportunities when the First Circuit on Monday said...To view the full article, register now.
Already a subscriber? Click here to view full article